Synthetic CRISPR-Cas gene activators for transcriptional reprogramming in bacteria

Nat Commun. 2018 Jun 27;9(1):2489. doi: 10.1038/s41467-018-04901-6.


Methods to regulate gene expression programs in bacterial cells are limited by the absence of effective gene activators. To address this challenge, we have developed synthetic bacterial transcriptional activators in E. coli by linking activation domains to programmable CRISPR-Cas DNA binding domains. Effective gene activation requires target sites situated in a narrow region just upstream of the transcription start site, in sharp contrast to the relatively flexible target site requirements for gene activation in eukaryotic cells. Together with existing tools for CRISPRi gene repression, these bacterial activators enable programmable control over multiple genes with simultaneous activation and repression. Further, the entire gene expression program can be switched on by inducing expression of the CRISPR-Cas system. This work will provide a foundation for engineering synthetic bacterial cellular devices with applications including diagnostics, therapeutics, and industrial biosynthesis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • CRISPR-Cas Systems*
  • Escherichia coli / genetics*
  • Escherichia coli / metabolism
  • Gene Editing
  • Gene Knockout Techniques
  • Genes, Synthetic / genetics*
  • Genome, Bacterial / genetics*
  • Metabolic Engineering / methods*
  • Metabolic Networks and Pathways / genetics
  • Transcription Initiation Site
  • Transcriptional Activation / genetics